NCT05371054 2026-02-23Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed8 enrolled 20 charts